
Blend · Vial
CJC-1295 + Ipamorelin
From CA$129A two-peptide blend used to explore how different signals influence the body’s growth-hormone system.

EternaGen / Research use onlyBlend · Research use only
A blend of the amylin analogue cagrilintide and the GLP-1 receptor agonist semaglutide (5mg each), explored in metabolic research.
Available to approved purchasers
Can’t find the right record?Send support the product name or batch code.
Contact supportProduct information
A blend of the amylin analogue cagrilintide and the GLP-1 receptor agonist semaglutide (5mg each), explored in metabolic research.
The combination has been evaluated in large clinical trials as a sponsor-manufactured product and is not approved in Canada. Those results do not establish the safety or performance of a separately prepared research blend.
Specifications
Supplier-origin documentation will be published only after EternaGen verifies the source and record details.